Enhancing Prospective Thinking in Early Recovery
The goal of this clinical trial is to use a novel virtual reality intervention to test for efficacy in reducing alcohol use and increasing abstinence, with concomitant increases in future self-identification, future time perspective, and delay-of-reward, in early recovering alcohol use disorder (AUD) persons. The main question[s] this trial aims to answer are:

Will the Virtual Reality (VR) intervention decrease the number of stimulant use days? Will the VR intervention produce longer abstinence periods during follow-up visits? Will the VR intervention increase alcohol abstinence rates? Will the VR intervention increase future self-identification? Will the VR intervention increase self-reported future time perspective? Will the VR intervention increase preference for delayed rewards in a laboratory delay discounting task on the study day? Will the VR intervention produce gains in the behavioral effects of future self-identification, future time perspective, and delayed rewards at the 30-day and 6-month follow-ups? Researchers will compare the experimental and control groups to see if there are differences in the results for the questions outlined above.
- EligibilityCriteria: Inclusion Criteria:  Abstinence between ≥14 days and ≤1 year Verbal endorsement of commitment to recovery Outpatient Psychotropic drugs for SUD-comorbidity Drug/alcohol abstinence ≥ 24 hours at the time of the study day visit English comprehension  Exclusion Criteria:  Unstable medical disorders Habitual drug use Mu-opioid drugs Smell/taste disorders Unstable psychiatric conditions Extravagant/elaborate face tattoos - HealthyVolunteers: No - Gender: All - MinimumAge: 18 Years - MaximumAge: 60 Years - StdAgeList: Adult